JP2010531892A5 - - Google Patents

Download PDF

Info

Publication number
JP2010531892A5
JP2010531892A5 JP2010515078A JP2010515078A JP2010531892A5 JP 2010531892 A5 JP2010531892 A5 JP 2010531892A5 JP 2010515078 A JP2010515078 A JP 2010515078A JP 2010515078 A JP2010515078 A JP 2010515078A JP 2010531892 A5 JP2010531892 A5 JP 2010531892A5
Authority
JP
Japan
Prior art keywords
peptide
composition
plg
radsradc
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010515078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010531892A (ja
JP5568008B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/068186 external-priority patent/WO2009003037A1/en
Publication of JP2010531892A publication Critical patent/JP2010531892A/ja
Publication of JP2010531892A5 publication Critical patent/JP2010531892A5/ja
Application granted granted Critical
Publication of JP5568008B2 publication Critical patent/JP5568008B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010515078A 2007-06-27 2008-06-25 ペプチドチロシナーゼインヒビターおよびその使用 Expired - Fee Related JP5568008B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93733107P 2007-06-27 2007-06-27
US60/937,331 2007-06-27
PCT/US2008/068186 WO2009003037A1 (en) 2007-06-27 2008-06-25 Peptide tyrosinase inhibitors and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014085691A Division JP2014193163A (ja) 2007-06-27 2014-04-17 ペプチドチロシナーゼインヒビターおよびその使用

Publications (3)

Publication Number Publication Date
JP2010531892A JP2010531892A (ja) 2010-09-30
JP2010531892A5 true JP2010531892A5 (enExample) 2011-08-11
JP5568008B2 JP5568008B2 (ja) 2014-08-06

Family

ID=40186023

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010515078A Expired - Fee Related JP5568008B2 (ja) 2007-06-27 2008-06-25 ペプチドチロシナーゼインヒビターおよびその使用
JP2014085691A Pending JP2014193163A (ja) 2007-06-27 2014-04-17 ペプチドチロシナーゼインヒビターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014085691A Pending JP2014193163A (ja) 2007-06-27 2014-04-17 ペプチドチロシナーゼインヒビターおよびその使用

Country Status (7)

Country Link
US (2) US8026208B2 (enExample)
EP (1) EP2180897B1 (enExample)
JP (2) JP5568008B2 (enExample)
KR (1) KR101507188B1 (enExample)
CN (2) CN103864892A (enExample)
CA (1) CA2728140C (enExample)
WO (1) WO2009003037A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641591B1 (en) 1999-08-26 2003-11-04 John H. Shadduck Instruments and techniques for controlled removal of epidermal layers
US8048089B2 (en) 2005-12-30 2011-11-01 Edge Systems Corporation Apparatus and methods for treating the skin
US9566088B2 (en) 2006-03-29 2017-02-14 Edge Systems Llc Devices, systems and methods for treating the skin
US10172644B2 (en) 2006-03-29 2019-01-08 Edge Systems Llc Devices, systems and methods for treating the skin
GB0612669D0 (en) * 2006-06-27 2006-08-09 Univ Leeds Biomarkers for preeclampsia
JP5568008B2 (ja) * 2007-06-27 2014-08-06 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ペプチドチロシナーゼインヒビターおよびその使用
EP2240099B1 (en) 2008-01-04 2018-02-21 Edge Systems LLC Apparatus for treating the skin
WO2009097451A1 (en) 2008-01-29 2009-08-06 Edge Systems Corporation Apparatus and method for treating the skin
US8814836B2 (en) 2008-01-29 2014-08-26 Edge Systems Llc Devices, systems and methods for treating the skin using time-release substances
US8999916B2 (en) 2010-03-31 2015-04-07 Agency For Science, Technology And Research Crosslinked peptide hydrogels
US9067084B2 (en) 2010-03-31 2015-06-30 Agency For Science, Technology And Research Amphiphilic linear peptide/peptoid and hydrogel comprising the same
US9687591B2 (en) 2010-03-31 2017-06-27 Agency For Science, Technology And Research Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes
WO2011154640A2 (fr) * 2010-06-11 2011-12-15 Galderma Research & Development Modulateurs de trmp1, mmp2, mia ou ptgs1 dans le traitement du melasma
WO2011154639A2 (fr) * 2010-06-11 2011-12-15 Galderma Research & Development Modulateurs de edn3 et/ou ednrb dans le traitement du melasma
WO2012154959A1 (en) * 2011-05-11 2012-11-15 Elixir Institute Of Regenerative Medicine Peptide tyrosinase inhibitors and uses thereof
JP6026765B2 (ja) * 2012-04-24 2016-11-16 花王株式会社 チロシナーゼ阻害剤
EP2958933B1 (en) * 2013-01-28 2018-08-22 Agency For Science, Technology And Research Crosslinked peptide hydrogels
EP3437575B1 (en) 2013-03-15 2021-04-21 Edge Systems LLC Devices and systems for treating the skin
US10238812B2 (en) 2013-03-15 2019-03-26 Edge Systems Llc Skin treatment systems and methods using needles
EP3795204B1 (en) 2014-12-23 2023-10-25 HydraFacial LLC Device for treating the skin using a rollerball
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
CN107920948A (zh) 2015-07-08 2018-04-17 边缘系统有限公司 用于促进毛发生长的装置、系统和方法
KR101895906B1 (ko) * 2016-07-07 2018-10-04 주식회사 한국화장품제조 펩타이드 리포좀을 포함하는 스틱형 화장료 조성물
WO2018013609A2 (en) 2016-07-11 2018-01-18 The Regents The University Of California Synthetic melanin nanoparticles uses thereof
CN109689676B (zh) * 2016-09-15 2022-10-18 帝斯曼知识产权资产管理有限公司 新型化合物
US11433012B2 (en) 2017-11-14 2022-09-06 Conopco, Inc. Peptides for increasing melanin in melanocytes
CA3084853A1 (en) 2017-12-06 2019-06-13 Unilever Plc A skin darkening composition
CN109180785B (zh) * 2018-11-08 2021-08-20 中国科学院上海应用物理研究所 一种具有抑制黑色素生成和抗紫外线损伤作用的美白还原多肽及其应用
WO2021087076A1 (en) * 2019-10-30 2021-05-06 Northwestern University Selenium-containing analogues of pheomelanin and related materials and methods of making
US11291474B2 (en) 2020-01-06 2022-04-05 Ed F. Nicolas Skin treatment tool applicator tip
CN115916800A (zh) * 2020-02-13 2023-04-04 伊斯盖普治疗公司 黑色素瘤治疗
KR102506020B1 (ko) * 2020-11-27 2023-03-06 웰펩 주식회사 항산화 활성 및 티로시나제 저해활성을 갖는 펩타이드 및 이를 포함하는 조성물
USD1016615S1 (en) 2021-09-10 2024-03-05 Hydrafacial Llc Container for a skin treatment device
USD1065551S1 (en) 2021-09-10 2025-03-04 Hydrafacial Llc Skin treatment device
CN118201659A (zh) 2021-09-10 2024-06-14 海菲秀公司 用于处理皮肤的装置、系统和方法
USD1116120S1 (en) 2021-10-11 2026-03-03 Hydrafacial Llc Skin treatment device
USD1042807S1 (en) 2021-10-11 2024-09-17 Hydrafacial Llc Skin treatment tip
USD1112778S1 (en) 2022-03-04 2026-02-10 Hydrafacial Llc Light therapy device for skin care
US12377036B2 (en) 2022-06-21 2025-08-05 Northwestern University Melanin hair dye with thickeners
USD1084369S1 (en) 2023-02-10 2025-07-15 Hydrafacial Llc Skin treatment tip
CN117106016A (zh) * 2023-09-01 2023-11-24 海南大学 阿胶源酪氨酸酶抑制肽及其应用
CN117106015B (zh) * 2023-09-01 2024-04-26 海南大学 一种椰子源活性肽及其应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) * 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3978427A (en) * 1973-06-15 1976-08-31 American Optical Corporation Erbium laser device having non-masking laser rod holders
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
GB2103622B (en) * 1981-06-16 1986-01-15 Genentech Inc Production of foot and mouth disease vaccine from microbially expressed antigens
US4421769A (en) * 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
IT1164225B (it) * 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
EP0389950A1 (en) * 1989-03-23 1990-10-03 Lion Corporation Melanocyte-stimulating hormone inhibitor and external preparation containing the same
US5773291A (en) * 1989-04-26 1998-06-30 Sloan-Kettering Institute For Cancer Research Non-melanotytic mammalian cell constitutively expressing biologically active human tyrosinase and use thereof
AU6428890A (en) * 1989-09-12 1991-04-18 Regents Of The University Of California, The Therapeutic peptides and proteins
US5543389A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
AU1194092A (en) * 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5256766A (en) * 1991-02-19 1993-10-26 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
JPH08502883A (ja) 1992-08-21 1996-04-02 ヴァー ファルム アーベー ヒトメラノサイト刺激ホルモンレセプター
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5455228A (en) * 1993-07-02 1995-10-03 The Research Foundation Of State University Of New York Peptidase resistant thrombin receptor peptide ligand
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US5589460A (en) * 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
CN1179105A (zh) * 1995-01-17 1998-04-15 小马克·奎伦 α-促黑激素拮抗剂及相关方法
US6602856B1 (en) * 1995-01-17 2003-08-05 J. Mark Quillan Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
US5854204A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals, Inc. Aβ peptides that modulate β-amyloid aggregation
WO1996040033A1 (en) * 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
AU723585B2 (en) * 1996-03-28 2000-08-31 Trustees Of Boston University Methods of modulating melanin synthesis
US6143723A (en) * 1996-05-20 2000-11-07 Ramaiah; Abburi Pigmentory agent
KR100478928B1 (ko) * 1996-11-08 2005-08-18 세이렌가부시끼가이샤 세리신또는세리신가수분해물을유효성분으로하는비의약용항산화제,화장품,식품변색방지제,음식물,심근경색치료제,동맥경화치료제,당뇨병치료제,암치료제,또는뇌줄중치료제
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US8039026B1 (en) * 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US6256533B1 (en) * 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US20020034772A1 (en) * 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US7083781B2 (en) * 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
PL363153A1 (en) * 2000-06-16 2004-11-15 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
EP1367961B1 (en) * 2001-02-06 2008-12-31 Massachusetts Institute Of Technology Peptide scaffold encapsulation of tissue cells and uses thereof
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
EP1381349A4 (en) * 2001-04-27 2004-09-29 Gen Hospital Corp TYROSINASEBESTIMMUNG
US7658742B2 (en) * 2001-11-21 2010-02-09 Envy Medical, Inc. Skin treatment system and method of use
US6695853B2 (en) * 2001-11-21 2004-02-24 Emed, Inc. Microdermabrasion system and method of use
US6649150B2 (en) * 2002-04-11 2003-11-18 Em Industries Skin-lightening
US7025957B2 (en) * 2002-09-06 2006-04-11 Desert Whale Jojoba Company Composition and method to whiten skin
US7125572B2 (en) 2004-05-14 2006-10-24 Kaoder Industry Company, Ltd. Tyrosinase inhibitor extract
EP1913157B2 (en) 2005-06-28 2016-10-26 Genentech, Inc. Egfr and kras mutations for prediction of patient response to egfr inhibitor treatment
JP4742365B2 (ja) 2005-10-04 2011-08-10 独立行政法人産業技術総合研究所 チロシナーゼ阻害剤、美白剤および美白外用剤
JP5568008B2 (ja) * 2007-06-27 2014-08-06 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ペプチドチロシナーゼインヒビターおよびその使用

Similar Documents

Publication Publication Date Title
JP2011504165A5 (enExample)
JP6469949B2 (ja) 体臭抑制用の皮膚洗浄用組成物
RU2013121788A (ru) Ингибиторы репликации вич
EP4442241A3 (en) Retinol replacement in skin treatment
BR112012029959A2 (pt) compostos de carbamato de mentila como ativos para clareamento de pele e/ou cabelo
WO2011047868A3 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
WO2009100513A3 (pt) Peptideo des-[asp1hala1]- agonista da angiotensina-(1 -7) e composiҫões farmacêuticas para tratamento de doenças
CO6190598A2 (es) Composiciones farmaceuticas y metodo para el tratamiento de la inflamacion en el ganado y en otros animales
RU2011123700A (ru) Нонапептид с противоопухолевой активностью
JP2010517987A (ja) 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用
JP2016501866A5 (enExample)
JP2016513107A5 (enExample)
JP2015528479A5 (enExample)
EP3484462B1 (en) 5-hydroxytryptamine 1b receptor-stimulating agent for skin and/or hair repair
CL2007003318A1 (es) Compuestos derivados de 4,5-difenil-pirrol-2-carboxamida; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento o la prevencion de enfermedades tales como sindrome de abstinencia a una sustancia, t
WO2009106715A3 (fr) Peptide derive d'une proteine de la famille des aquaporines
JP2012197276A (ja) 皮膚病の治療用組成物、並びにそれを用いた製剤及びその調製方法
KR101689876B1 (ko) 펩타이드와 아미노산의 혼합물을 함유하는 여드름 개선용 화장료 조성물
WO2025049521A3 (en) Aryl ether analogs as inhibitors of the menin-mll interaction
ES2561814T3 (es) Tratamiento de infecciones micóticas
JP2015537028A5 (enExample)
KR20160025950A (ko) 여드름 개선용 화장료 조성물
JP5059408B2 (ja) 爪用外用剤
JP2017222676A5 (enExample)
JPWO2007148831A1 (ja) 亜鉛を有効成分として含有するコラーゲン合成促進剤